Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population

Neuroscience Letters

Volumn 350, Issue 1, 2003, Pages 25-28

  Yang, J D ^a,b   Feng, G Y ^c   Zhang, J ^b   Cheung, J ^d   St Clair, D ^d   He, L ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI MENTAL HEALTH CENTER   (China)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Alzheimer's disease; Apolipoprotein E; Chinese; Haplotype; Linkage disequilibrium; Stratification

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; APOE GENE; ARTICLE; CHINA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE INSERTION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR;

EID: 0142075287     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00815-2     Document Type: Article

References (27)

1. Ahmed A.R., MacGowan S.H., Culpan D., Jones R.W., Wilcock G.K. The -491A/T polymorphism of the apolipoprotein E gene is associated with the ApoE 4 allele and Alzheimer's disease. Neurosci. Lett. 263:1999;217-219.
2. Artiga M.J., Bullido M.J., Frank A., Sastre I., Recuero M., Garcia M.A., Lendon C.L., Han S.W., Morris J.C., Vazquez J., Goate A., Valdivieso F. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum. Mol. Genet. 7:(12):1998;1887-1892.
3. Artiga M.J., Bullido M.J., Sastre I., Recuero M., Garcia M.A., Aldudo J., Vazquez J., Valdivieso F. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett. 421:1998;105-108.
4. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., Lendon C., Han S.W., Morris J.C., Frank A., Vazquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet. 18:1998;69-71.
5. Chen L., Baum L., Ng H.K., Chan L.Y., Sastre I., Artiga M.J., Valdivieso F., Bullido M.J., Chiu H.F., Pang C.P. Apolipoprotein E promoter and α-2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease. Neurosci. Lett. 269:1999;173-177.
6. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C. Jr., Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7:(2):1994;180-184.
7. Fullerton S.M., Clark A.G., Weiss K.M., Nickerson D.A., Taylor S.L., Stengard J.H., Salomaa V., Vartiainen E., Perola M., Boerwinkle E., Sing C.F. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am. J. Hum. Genet. 67:(4):2000;881-900.
8. Helisalmi S., Hiltunen M., Valonen P., Mannermaa A., Koivisto A.M., Lehtovirta M., Ryynanen M., Soininen H. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals. J. Neurol. 246:1999;821-824.
9. Jean-Charles L., Louisa G., Liisa M. APOE promoter polymorphisms -219 and -491 contribute to Alzheimer's disease susceptibility: a combined analysis of six independent Caucasian samples. Neurology. 2003;. in press.
10. Lambert J.C., Berr C., Pasquier F., Delacourte A., Frigard B., Cottel D., Perez-Tur J., Mouroux V., Mohr M., Cecyre D., Galasko D., Lendon C., Poirier J., Hardy J., Mann D., Amouyel P., Chartier-Harlin M.C. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE expression and risk of developing Alzheimer's disease. Hum. Mol. Genet. 7:1998;1511-1516.
11. Lambert J.C., Pasquier F., Cottel D., Frigard B., Amouyel P., Chartier-Harlin M.C. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum. Mol. Genet. 7:1998;533-540.
12. Lambert J.C., Perez-Tur J., Dupire M.J., Galasko D., Mann D., Amouyel P., Hardy J., Delacourte A., Chartier-Harlin M.C. Distortion of allelic expression of apolipoprotein E in Alzheimer disease. Hum. Mol. Genet. 6:1997;2151-2154.
13. Licastro F., Pedrini S., Govoni M., Pession A., Ferri C., Annoni G., Casadei V., Veglia F., Bertolini S., Grimaldi L.M. Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease. Neurosci. Lett. 270:1999;129-132.
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:(7):1984;939-944.
15. Mui S., Briggs M., Chung H., Wallace R.B., Gomez-Isla T., Rebeck G.W., Hyman B.T. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele. Neurology. 47:1996;196-201.
16. Nickerson D.A., Taylor S.L., Fullerton S.M., Weiss K.M., Clark A.G., Stengard J.H., Salomaa V., Boerwinkle E., Sing C.F. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res. 10:(10):2000;1532-1545.
17. Rebeck G.W., Cheung B.S., Growdon W.B., Deng A., Akuthota P., Locascio J., Greenberg S.M., Hyman B.T. Lack of independent associations of Apolipoprotein E promoter and intron I polymorphisms with Alzheimer's disease. Neurosci. Lett. 272:1999;155-158.
18. Roks G., Cruts M., Bullido M.J., Backhovens H., Artiga M.J., Hofman A., Valdivieso F., Van Broeckhoven C., Van Duijn C.M. The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease. Neurosci. Lett. 258:1998;65-68.
19. Song Y.Q., Rogaeva E., Premkumar S., Brindle N., Kawarai T., Orlacchio A., Yu G., Levesque G., Nishimura M., Ikeda M., Pei Y., O'Toole C., Duara R., Barker W., Sorbi S., Freedman M., Farrer L., St George-Hyslop P. Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE. Neurosci. Lett. 250:1998;189-192.
20. Strittmatter W., Roses A. Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 19:1996;53-77.
21. Thome J., Gewirtz J.C., Sakai N., Zachariou V., Retz-Junginger P., Retz W., Duman R.S., Rosler M. Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia? Neurosci. Lett. 274:1999;37-40.
22. Toji H., Maruyama H., Sasaki K., Nakamura S., Kawakami H. Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population. Neurosci. Lett. 259:1999;56-58.
23. Town T., Paris D., Fallin D., Duara R., Barker W., Gold M., Crawford F., Mullan M. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Neurosci. Lett. 252:1998;95-98.
24. Wang J.C., Kwon J.M., Shah P., Morris J.C., Goate A. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease. Neurology. 55:2000;1644-1649.
25. Wenham P.R., Price W.H., Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 337:1991;1158-1159.
26. Woolf B. On estimating the relation between blood groups and disease. Ann. Hum. Genet. 19:1955;251-253.
27. Xu Y., Berglund L., Ramakrishnan R., Mayeux R., Ngai C., Holleran S., Tycko B., Leff T., Shachter N.S. A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. Lipid Res. 40:(1):1999;50-58.